Tonghua Dongbao Plans to Subscribe Up to 162 Million Yuan in Amoytop Biotech Convertible Bonds

Stock News

07/27

Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA: 600867) has announced its intention to participate in the subscription of convertible bonds issued by its associate company, Xiamen Amoytop Biotech Co., Ltd. (SHA: 688278).

According to the company's announcement, Amoytop Biotech plans to issue convertible bonds to unspecified investors, with a total fundraising amount not exceeding 1.533 billion yuan. Tonghua Dongbao will exercise its preemptive rights to subscribe for these bonds. The total investment principal for this subscription is capped at 162 million yuan.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1159863253"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1159863253\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1159863253?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-27 16:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1159863253","market":"sg","top_or_hot":-1,"title":"Tonghua Dongbao Plans to Subscribe Up to 162 Million Yuan in Amoytop Biotech Convertible Bonds","media":"Stock News","content":"<p><b>Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA: 600867)</b> has announced its intention to participate in the subscription of convertible bonds issued by its associate company, <b>Xiamen Amoytop Biotech Co., Ltd. (SHA: 688278)</b>.<br><br>According to the company's announcement, Amoytop Biotech plans to issue convertible bonds to unspecified investors, with a total fundraising amount not exceeding 1.533 billion yuan. Tonghua Dongbao will exercise its preemptive rights to subscribe for these bonds. The total investment principal for this subscription is capped at 162 million yuan.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tonghua Dongbao Plans to Subscribe Up to 162 Million Yuan in Amoytop Biotech Convertible Bonds</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTonghua Dongbao Plans to Subscribe Up to 162 Million Yuan in Amoytop Biotech Convertible Bonds\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2026-07-27 16:04</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><b>Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA: 600867)</b> has announced its intention to participate in the subscription of convertible bonds issued by its associate company, <b>Xiamen Amoytop Biotech Co., Ltd. (SHA: 688278)</b>.<br><br>According to the company's announcement, Amoytop Biotech plans to issue convertible bonds to unspecified investors, with a total fundraising amount not exceeding 1.533 billion yuan. Tonghua Dongbao will exercise its preemptive rights to subscribe for these bonds. The total investment principal for this subscription is capped at 162 million yuan.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688278","symbol_name":"特寶生物","start_time":0,"source_url":"","article_id":"1159863253","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1159863253","pubTimestamp":1785139464,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA: 600867) has announced its intention to participate in the subscription of convertible bonds issued by its associate company, Xiamen Amoytop Biotech Co.,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600867":"通化东宝","688278":"特宝生物","BK0188":"融资融券","BK0196":"行业龙头","FCEF":"First Trust Income Opportunities ETF","BK0239":"医药制造","SABA":"Saba Capital Income & Opportunities Fund II"},"translate_title":"通化东宝计划认购至多1.62亿元的Amoytop生物可转换债券","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600867":1,"688278":1,"SABA":1,"FCEF":1},"content_text":"Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA: 600867) has announced its intention to participate in the subscription of convertible bonds issued by its associate company, Xiamen Amoytop Biotech Co., Ltd. (SHA: 688278).According to the company's announcement, Amoytop Biotech plans to issue convertible bonds to unspecified investors, with a total fundraising amount not exceeding 1.533 billion yuan. Tonghua Dongbao will exercise its preemptive rights to subscribe for these bonds. The total investment principal for this subscription is capped at 162 million yuan.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}